Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Published in: European Journal of Nutrition 6/2014

01-09-2014 | Review

Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials

Authors: Saman Khalesi, Jing Sun, Nicholas Buys, Arash Jamshidi, Elham Nikbakht-Nasrabadi, Hossein Khosravi-Boroujeni

Published in: European Journal of Nutrition | Issue 6/2014

Login to get access

Abstract

Purpose

Although previous literature has reported that regular green tea consumption may improve blood pressure, the evidence from these studies is not consistent. The present study systematically reviewed randomised controlled trials and examined the effect of green tea consumption on blood pressure using meta-analysis.

Methods

Search of ProQuest, PubMed, Scopus and Cochrane Library (CENTERAL) was conducted, to identify eligible articles. Articles from 1995 to 2013 were included. A random-effect model was chosen to calculate the effect of combined trials.

Result

Thirteen studies were included in the meta-analysis. Green tea consumption significantly changed systolic blood pressure, by −2.08 mm Hg (95 % CI −3.06, −1.05), and diastolic blood pressure, by −1.71 mm Hg (95 % CI −2.86, −0.56), compared to the control. Changes in lipid profile, blood glucose and body mass index were also assessed in the meta-analysis. A significant reduction was found in total cholesterol (−0.15 mmol/L [95 % CI −0.27, −0.02]) and low-density lipoprotein cholesterol (−0.16 mmol/L [95 % CI −0.22, −0.09]). Changes in other parameters did not reach statistical significance. Subgroup analysis suggested a greater reduction in both systolic and diastolic blood pressure in studies that included participants with a baseline mean systolic blood pressure of ≥130 mm Hg, and studies involving consuming green tea as an extract.

Conclusion

The present meta-analysis suggests that green tea and its catechins may improve blood pressure, and the effect may be greater in those with systolic blood pressure ≥130 mm Hg. The meta-analysis also suggests that green tea catechins may improve total and low-density lipoprotein cholesterol.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS (2012) Heart disease and stroke statistics—2012 update a report from the American Heart Association. Circulation 125(1):e2–e220CrossRef
4.
Law M, Wald N, Morris J (2005) Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Int J Technol Assess Health Care 21(1):145. doi:10.​1017/​s026646230522019​6
5.
Qureshi A, Sapkota B (2011) Blood pressure reduction in secondary stroke prevention. Continuum (Minneapolis, Minn) 17 (6 2ndary Stroke Prevention):1233
6.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252CrossRef
7.
Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88(1):38–50
8.
Rains TM, Agarwal S, Maki KC (2011) Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22(1):1–7CrossRef
9.
Balentine DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37(8):693–704CrossRef
10.
Bhardwaj P, Khanna D (2013) Green tea catechins: defensive role in cardiovascular disorders. Chin J Nat Med 11(4):345–353
11.
12.
Maruyama K, Iso H, Sasaki S, Fukino Y (2009) The association between concentrations of green tea and blood glucose levels. J Clin Biochem Nutr 44(1):41CrossRef
13.
Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH (2005) Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 116(6):972–983CrossRef
14.
Sun C-L, Yuan J-M, Koh W-P, Mimi CY (2006) Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27(7):1310–1315CrossRef
15.
Antonello M, Montemurro D, Bolognesi M, Di Pascoli M, Piva A, Grego F, Sticchi D, Giuliani L, Garbisa S, Rossi GP (2007) Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 20(12):1321–1328CrossRef
16.
17.
Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai B-O, Auvichayapat N, Thinkhamrop B, Kunhasura S, Wongpratoom S, Sinawat S, Hongprapas P (2008) Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav 93(3):486–491CrossRef
18.
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRef
19.
Liberati A, Moher D, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. doi:10.​1371/​journal.​pmed.​1000100 CrossRef
20.
Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health 52(6):377–384CrossRef
21.
22.
Harrison RA, Siminoski K, Vethanayagam D, Majumdar SR (2007) Osteoporosis-related kyphosis and impairments in pulmonary function: a systematic review. J Bone Miner Res 22(3):447–457CrossRef
23.
Higgins J, Green SP, Wiley I, Cochrane C (2008) Cochrane handbook for systematic reviews of interventions. vol Book, Whole. Wiley-Blackwell, HobokenCrossRef
24.
Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Medical Research Council, UK
25.
26.
Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI, Phung OJ (2011) Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc 111(11):1720–1729CrossRef
27.
Dong J-Y, Szeto IM, Makinen K, Gao Q, Wang J, Qin L-Q, Zhao Y (2013) Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 110(07):1188–1194CrossRef
28.
Sone T, Kuriyama S, Nakaya N, Hozawa A, Shimazu T, Nomura K, Rikimaru S, Tsuji I (2011) Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res 55:1–10. doi:10.​3402/​fnr.​v55i0.​8326 CrossRef
29.
Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ (2011) Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27(2):206–213. doi:10.​1016/​j.​nut.​2010.​01.​015 CrossRef
30.
Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 51(5):335–342CrossRef
31.
Bogdanski P, Suliburska J, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A (2012) Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res 32(6):421–427. doi:10.​1016/​j.​nutres.​2012.​05.​007 CrossRef
32.
Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JP, Minihane AM, Rimbach G (2009) Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 139(1):58–62. doi:10.​3945/​jn.​108.​096412 CrossRef
33.
Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P (2011) Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev 16(2):157–163CrossRef
34.
Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27(3):363–370CrossRef
35.
36.
Nantz MP, Rowe CA, Bukowski JF, Percival SS (2009) Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 25(2):147–154CrossRef
37.
Suliburska J, Bogdanski P, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A (2012) Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res 149(3):315–322. doi:10.​1007/​s12011-012-9448-z CrossRef
38.
Vieira Senger AE, Schwanke CHA, Gomes I, Valle Gottlieb MG (2012) Effect of green tea (Camellia sinensis) consumption on the components of metabolic syndrome in elderly. J Nutr Health Aging 16(9):738–742. doi:10.​1007/​s12603-012-0081-5 CrossRef
39.
Diepvens K, Kovacs EM, Nijs IM, Vogels N, Westerterp-Plantenga MS (2005) Effect of green tea on resting energy expenditure and substrate oxidation during weight loss in overweight females. Br J Nutr 94(6):1026–1034CrossRef
40.
Chantre P, Lairon D (2002) Recent findings of green tea extract AR25 (exolise) and its activity for the treatment of obesity. Phytomedicine 9(1):3–8CrossRef
41.
42.
Islam MA (2012) Cardiovascular effects of green tea catechins: progress and promise. Recent Pat Cardiovasc Drug Discov 7(2):88–99CrossRef
43.
Rastaldo R, Pagliaro P, Cappello S, Penna C, Mancardi D, Westerhof N, Losano G (2007) Nitric oxide and cardiac function. Life Sci 81(10):779–793CrossRef
44.
Gössl M, Lerman A (2006) Endothelin beyond a vasoconstrictor. Circulation 113(9):1156–1158CrossRef
45.
Collins QF, Liu H-Y, Pi J, Liu Z, Quon MJ, Cao W (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. J Biol Chem 282(41):30143–30149CrossRef
46.
47.
Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J (2003) Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 163(12):1448–1453CrossRef
48.
Koo SI, Noh SK (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18(3):179–183CrossRef
49.
Bursill CA, Abbey M, Roach PD (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193(1):86–93CrossRef
50.
Ikeda I, Kobayashi M, Hamada T, Tsuda K, Goto H, Imaizumi K, Nozawa A, Sugimoto A, Kakuda T (2003) Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J Agric Food Chem 51(25):7303–7307CrossRef
51.
Hsu T, Kusumoto A, Abe K, Hosoda K, Kiso Y, Wang M, Yamamoto S (2006) Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur J Clin Nutr 60(11):1330–1336CrossRef
52.
Westerterp-Plantenga MS (2010) Green tea catechins, caffeine and body-weight regulation. Physiol Behav 100(1):42–46CrossRef
53.
Rains TM, Agarwal S, Maki KC (2011) Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22(1):1–7CrossRef
54.
Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D (2003) Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr Cancer 45(2):226–235CrossRef
55.
Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM (2005) Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23(5):921–928CrossRef
56.
Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJP, Bittner V, Fruchart J-C, Treating New Targets I, Treating to New Targets I (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357(13):1301–1310. doi:10.​1056/​NEJMoa064278 CrossRef
Metadata
Title
Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials
Authors
Saman Khalesi
Jing Sun
Nicholas Buys
Arash Jamshidi
Elham Nikbakht-Nasrabadi
Hossein Khosravi-Boroujeni
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 6/2014
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-014-0720-1

Other articles of this Issue 6/2014

European Journal of Nutrition 6/2014 Go to the issue

Original Contribution

Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population

Short Communication

High-fat feeding increases hepatic vitamin C synthesis and its circulatory mobilization in mice

Original Contribution

Dietary factors associated with metabolic risk score in Finnish children aged 6–8 years: the PANIC study

Original Contribution

Effect of white tea (Camellia sinensis (L.)) extract in the glycolytic profile of Sertoli cell

Original Contribution

Dietary fructose-related adiposity and glucocorticoid receptor function in visceral adipose tissue of female rats

Original Contribution

Short-term creatine supplementation does not reduce increased homocysteine concentration induced by acute exercise in humans
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits